Summary Information:
Jazz Pharmaceuticals plc Common Stock (Ireland)
NASDAQ:JAZZ


email
admin@troach.net
Our Main Pages
Stocks.TRoach.Net
TRoach.Org
TRoach.Net

NOTE: This page is for evaluation of a JFF Project.
This page is NOT updated on a regular basis.
Information on this page should NOT be used for investment purposes.


Jazz Pharmaceuticals plc Common Stock (Ireland)
Exchange: NASDAQ
Symbol: JAZZ
SEC CIK: 0001232524
Phone: 353-1-634-7800
FIFTH FLOOR, WATERLOO EXCHANGE
WATERLOO ROAD
DUBLIN L2 4
CEO:
Price when page updated: 114.57 Date: 2023-11-30
Company Website:
www.jazzpharma.com

_Description: Jazz Pharmaceuticals plc is a global biopharmaceutical company dedicated to developing and commercializing life-changing medicines that transform the lives of patients with serious diseases - often with limited or no options. Jazz Pharmaceuticals plc has a diverse portfolio of marketed medicines and novel product candidates, from early- to late-stage development, in key therapeutic areas. The company's focus is in neuroscience, including sleep and movement disorders, and in oncology, including hematologic and solid tumors. They actively explore new options for patients including novel compounds, small molecule advancements, biologics and innovative delivery technologies. Jazz is headquartered in Dublin, Ireland and has employees around the globe, serving patients in more than 90 countries.

IPO YEAR:
2007
Sector:
Health Care
Industry:
Biotechnology: Pharmaceutical Preparations
ADRTSO:

MarketCap:
7212973522.00
Beta:
0.677163977452199
52 Week High:
169.89
52 Week Low:
125.36
52 Week Change:
-0.13798486850005998
Short Interest:

Short Date:

Shares Outstanding:
63331430
Dividend Rate:
0
Dividend Yield:
1.75%
ExDividend Date:

Latest EPS:

Latest EPS Date:
26 Apr 2023
Float:
0
return on Equity:
-7.10%
Consensus EPS:

Number Of Estimates:

EPS Surprise Dollar:

Eps Surprise Percent:

EBITDA:
$1.922B
ttmEPS:
-3.58
Revenue:
$3.792B
Gross Profit:

Cash:

Debt:

Institution Percent:
95.70%
Revenue Percent:

Revenue Per Employee:

Insider Percent:
2.90%
Return on Assets:
-2.00%
Return on Capital:

Profit Margin:
-6.10%
Price to Sales:
2.51
Price To Book:
2.97
Short Ratio:

PE Ratio:
-40.57779206819602
Employees:
3200
1Y Guesstimate
188.730:1.0:4




__The following are links to various summary and news pages for
__Jazz Pharmaceuticals plc Common Stock (Ireland) [ JAZZ ].

__Note: Some Links might not have information for the company.


finance.Yahoo.com money.CNN.com NASDAQ research
WalletInvestor.com WSJ.com MarketBeat.com
finviz.com WallMine.com TheGlobeandMail.com
stock1010.com
NASDAQ - General Info SEC Insider Report Ownership Summary
Dividend History insiderbuyingselling.com
Facebook search Twitter search LinkedIn search
PRnewsWire.Com Google Forecast
tdameritrade.com BarChart.com
SeekingAlpha.com Markets.FT.com stocktwits.com
FinTel.io Ldmicro.com bloomberg.com
MarketWatch.com Reuters.com businessinsider.com
fool.com barrons.com zacks.com
GuruFocus.com Investing.com tipranks.com
thestreet.com nytimes.com earningswhispers.com
marketchameleon.com sunshineavenue.com stockinvest.us
stockanalysis.com stockconsultant.com ycharts.com
financialcontent.com docoh.com foxbusiness.com
cnbc.com investorsobserver.com tradingview.com
investopedia.com tmxmoney.com invest.cnyes.com
ask.com bing.com brave.com
duckduckgo.com ecosia.org excite.com
exalead.com gibiru.com hotbot.com
www.info.com infospace.com lycos.com
lukol.com metacrawler.com mojeek.com
becovi.com searx.thegpm.org search.com
swisscows.com webcrawler.com yahoo.com
yandex.com yep.com you.com




INDEX




Page design by: TRoach
Page Last Updated: 2023-11-30